Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Multicentre Study Evaluating Pazopanib in First-line Treatment of Poor-risk Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

NCT01521715 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT01521715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Multicentre Study Evaluating Pazopanib in First-line Treatment of Poor-risk Patients With Locally Advanced or Metastatic Renal Cell Carcinoma
Lead sponsor
iOMEDICO AG
Phase
Phase 4
Overall status
Completed
Start date
January 24, 2012
Completion date
July 31, 2017
Enrollment
44 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell, clear-cell metastatic renal cell carcinoma, locally advanced and/or metastatic renal cell carcinoma